Početna › Prekomjerna tjelesna masa › Alabama › Birmingham
Kliničke studije za Prekomjerna tjelesna masa u gradu Birmingham, AL
16 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u gradu Birmingham i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
U tijeku regrutacijaFaza 3
- Univ of Alabama Birmingham, Birmingham
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
U tijeku regrutacijaFaza 2
- University of Alabama - Birmingham, Birmingham
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
U tijeku regrutacijaFaza 3
- Univ of Alabama Birmingham, Birmingham
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
U tijeku regrutacijaFaza 3
- Central Research Associates, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
U tijeku regrutacijaFaza 3
- Birmingham Clinical Research, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
U tijeku regrutacijaFaza 3
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
U tijeku regrutacijaFaza 3
- AURORA-1 Clinical Site, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
U tijeku regrutacijaFaza 3
- AURORA-2 Clinical Site, Birmingham
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
U tijeku regrutacijaFaza 3
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
- ACCOMPLISH-2 Research Site, Birmingham
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
U tijeku regrutacijaFaza 3
- Uni of Alabama at Birmingham, Birmingham
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
U tijeku regrutacijaFaza 3
- Kailera Clinical Site, Birmingham
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
U tijeku regrutacijaFaza 3
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
Time-restricted Eating for Postpartum Weight Loss
U tijeku regrutacija
- University of Alabama at Birmingham, Birmingham
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
U tijeku regrutacija
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
U tijeku regrutacija
- The Worship Center Cristian Church, Birmingham
Studije za Prekomjerna tjelesna masa u drugim gradovima
- San Antonio, TX34 studija
- Houston, TX33 studija
- Chicago, IL28 studija
- Orlando, FL27 studija
- Las Vegas, NV23 studija
- Miami, FL23 studija
- Atlanta, GA20 studija
- Dallas, TX20 studija
- New York City, NY19 studija
- Jacksonville, FL19 studija
- Washington, DC19 studija
- Austin, TX18 studija
Ostale studije u gradu Birmingham
- Rak (sve vrste)30 studija
- Rak dojke24 studija
- Debljina23 studija
- Rak jajnika23 studija
- Nemikrocelularni karcinom pluća22 studija
- Akutna mijeloična leukemija21 studija
- Multipli mijelom18 studija
- KOPB17 studija
- Kardiovaskularne bolesti17 studija
- Rak endometrija16 studija
- Dijabetes tipa 216 studija
- Cistična fibroza16 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.